Results 21 to 30 of about 1,006,166 (271)

SERUM SICKNESS IN RABBITS [PDF]

open access: yesJournal of Experimental Medicine, 1931
Abstract The studies here reported relate primarily to the rôle that the lipids play in the causation of serum-sickness in rabbits. The word lipid is used as an inclusive term embracing all those substances removed from serum by commonly employed solvents such as alcohol, ether and similar materials.
L, Jones, M S, Fleisher
exaly   +5 more sources

Clinical characteristics, diagnosis, treatment, and prognosis of rituximab-induced serum sickness: a retrospective analysis of 39 reported cases [PDF]

open access: yesFrontiers in Immunology
BackgroundRituximab-induced serum sickness (RISS) is an uncommon delayed hypersensitivity reaction with incompletely characterized clinical features and management.
Yi Huang   +4 more
doaj   +2 more sources

Severe Reactions to Rituximab in Children: A Cohort Study of Rituximab-Induced Serum Sickness and Anaphylaxis [PDF]

open access: yesChildren
Background/Objectives: Severe infusion-related reactions to rituximab are rare; we aim to extend our knowledge about them in children, focusing on rituximab-induced serum sickness (RISS) and anaphylaxis.
Camille Feltesse   +8 more
doaj   +2 more sources

Streptokinase‐Induced Serum Sickness: A Case Report [PDF]

open access: yesClinical Case Reports
Serum sickness is rare; however, there is a significant hypersensitivity reaction to streptokinase used in different cardiac problems. Treatment often involves discontinuing the offending agent and administering corticosteroids. This case underscores the
Bibek Shrestha   +3 more
doaj   +2 more sources

Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review [PDF]

open access: yesCase Reports in Medicine, 2012
Serum sickness is an immune-complex-mediated systemic illness that can occur after treatment with monoclonal or polyclonal antibodies such as Rituxan (Rituximab) or antithymocyte globulin (Thymoglobulin), respectively.
Amarpreet Sandhu   +3 more
doaj   +2 more sources

Serum Sickness and Uveitis [PDF]

open access: yesCollegium antropologicum, 2005
Serum sickness is immune response to a foreign antigen, usually a heterologous protein. Incidence rate is less than 0.5%. Antigens and responding antibodies form circulating immunocomplex that is characteristic for serum sickness. The condition occurs 7-15 days after exposure to the antigen, usually with clinical picture of glomerulonephritis.
Biuk, Dubravka   +3 more
core   +5 more sources

Serum Sickness-Like Reaction: A Narrative Review of Epidemiology, Immunopathogenesis, Diagnostic Challenges, and Therapeutic Approaches [PDF]

open access: yesClinics and Practice
Serum sickness-like reaction (SSLR) is a rare immune-mediated condition that typically affects the skin and joints after exposure to certain drugs, infections, or vaccines.
Christodoulos Chatzigrigoriadis   +14 more
doaj   +2 more sources

Serum sickness-like reaction following an administration of the first dose of inactivated COVID19 vaccine [PDF]

open access: yesJAAD Case Reports, 2022
Sasipim Chaijaras, MD   +4 more
doaj   +2 more sources

Obinutuzumab‐induced serum sickness following salvage therapy for chronic lymphocytic leukemia [PDF]

open access: yesClinical Case Reports, 2017
Key Clinical Message The incidence of serum sickness following treatment of CLL with obinutuzumab has not been fully characterized, but is likely rare.
Julie Saba, Aaron C. Logan
doaj   +2 more sources

Serum Sickness after Equine Rabies Immunoglobulin in Identical Male Twins: Two Case Reports [PDF]

open access: yesCase Reports in Dermatology, 2019
We, hereby, report two cases of serum sickness in adult male identical twins who had received equine rabies immunoglobulin as a postexposure rabies treatment after cat scratches.
Weeratian Tawanwongsri   +1 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy